Literature DB >> 29080943

Author's Reply to Arnaud Uguen: "Non-Small-Cell Lung Cancer (NSCLC) Harboring ALK Translocations: Clinical Characteristics and Management in a Real-Life Setting: a French Retrospective Analysis (GFPC 02-14 Study)".

Jean-Bernard Auliac1, Christos Chouaid2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 29080943     DOI： 10.1007/s11523-017-0534-1

Source DB:  PubMed          Journal:  Target Oncol        ISSN： 1776-2596            Impact factor:   4.493


× No keyword cloud information.
  4 in total

1.  Comment on: "Non-Small-Cell Lung Cancer (NSCLC) Harboring ALK Translocations: Clinical Characteristics and Management in a Real-Life Setting: a French Retrospective Analysis (GFPC 02-14 Study)".

Authors:  Arnaud Uguen
Journal:  Target Oncol       Date:  2017-12       Impact factor: 4.493

2.  ALK Protein Analysis by IHC Staining after Recent Regulatory Changes: A Comparison of Two Widely Used Approaches, Revision of the Literature, and a New Testing Algorithm.

Authors:  Antonio Marchetti; Alessia Di Lorito; Maria Vittoria Pace; Manuela Iezzi; Lara Felicioni; Tommaso D'Antuono; Giampaolo Filice; Luigi Guetti; Felice Mucilli; Fiamma Buttitta
Journal:  J Thorac Oncol       Date:  2016-02-22       Impact factor: 15.609

3.  French multicentric validation of ALK rearrangement diagnostic in 547 lung adenocarcinomas.

Authors:  Sylvie Lantuejoul; Isabelle Rouquette; Hélène Blons; Nolwenn Le Stang; Marius Ilie; Hugues Begueret; Valerie Grégoire; Paul Hofman; Audrey Gros; Stephane Garcia; Nathalie Monhoven; Mojgan Devouassoux-Shisheboran; Audrey Mansuet-Lupo; Françoise Thivolet; Martine Antoine; Jean-Michel Vignaud; Frederique Penault-Llorca; Françoise Galateau-Sallé; Anne McLeer-Florin
Journal:  Eur Respir J       Date:  2015-04-30       Impact factor: 16.671

4.  Non-Small-Cell Lung Cancer (NSCLC) Harboring ALK Translocations: Clinical Characteristics and Management in a Real-Life Setting: a French Retrospective Analysis (GFPC 02-14 Study).

Authors:  Jean-Bernard Auliac; Isabelle Monnet; Catherine Dubos-Arvis; Anne Marie Chiappa; Nathalie Baize; Suzana Bota; Alain Vergnenegre; Helene Doubre; Chrystele Locher; Acya Bizieux; Gilles Robinet; Christos Chouaid
Journal:  Target Oncol       Date:  2017-12       Impact factor: 4.493
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.